Green Tea Extracts for Mild-to-moderate Diabetic Peripheral Neuropathy

Green Tea Extracts for Mild-to-moderate Diabetic Peripheral Neuropathy A Randomized Controlled Trial

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04543422

Enrollment

200

Registered

2020-09-10

Start date

2019-01-01

Completion date

2020-03-01

Last updated

2020-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Peripheral Neuropathy

Brief summary

the present randomized placebo-controlled study aimed to evaluate the effect of green tea extract administration on the clinical and neurophysiological parameters in patients with mild-to-moderate diabetic peripheral neuropathy.

Interventions

DIETARY_SUPPLEMENTGreen tea

Green tea extract capsules

OTHERPlacebo

Placebo containing inert material.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

20 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Diabetic patients with peripheral neuropathy

Exclusion criteria

* Patients under treatment of diabetic peripheral neuropathy. * Patients with other causes of peripheral neuropathy.

Design outcomes

Primary

Measure	Time frame	Description
Toronto Clinical Scoring System	three months	Improvement describes the difference between baseline and post-intervention outcome parameters

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026